These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28782312)

  • 1. Epidemiologic Surveillance of Glycemic Response to a Scored, Breakable, Extended Release, Fixed Dose Combination of Gliclazide and Metformin in Persons with Type 2 Diabetes.
    Kalra S; Das AK
    J Assoc Physicians India; 2017 Jun; 65(6):38-41. PubMed ID: 28782312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Type 2 Diabetes with a Breakable Extended Release Gliclazide Formulation in Primary Care: The Xrise Study.
    Mohan V; Chopra V; Sanyal D; Jain S; Jayaprakashsai J
    J Assoc Physicians India; 2015 Dec; 63(12):26-29. PubMed ID: 27666900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.
    Cho HY; Yoon H; Lim YC; Lee YB
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin extended release: metformin gastric retention, metformin GR, metformin XR.
    Drugs R D; 2005; 6(5):316-9. PubMed ID: 16128603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus.
    Erem C; Ozbas HM; Nuhoglu I; Deger O; Civan N; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):295-302. PubMed ID: 24710641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily.
    Guillausseau PJ; Greb W
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):133-7. PubMed ID: 11353879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized, multicentre study of the efficacy and safety of gliclazide-modified release in the treatment of Chinese type 2 diabetic patients.
    Lu CH; Chang CC; Chuang LM; Wang CY; Jiang YD; Wu HP
    Diabetes Obes Metab; 2006 Mar; 8(2):184-91. PubMed ID: 16448522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
    Bhansali A; Masoodi SR
    J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic control and cost analysis when changing from gliclazide co-administered with metformin to pre-combined glibenclamide-metformin tablets in type 2 diabetes mellitus.
    Lim PC; Lim SL; Oiyammaal C
    Med J Malaysia; 2012 Feb; 67(1):21-4. PubMed ID: 22582544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin plus gliclazide versus metformin plus glimepiride on cardiovascular risk factors in patients with type 2 diabetes mellitus.
    Hassan MH; Abd-Allah GM
    Pak J Pharm Sci; 2015 Sep; 28(5):1723-30. PubMed ID: 26408873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
    Perez A; Zhao Z; Jacks R; Spanheimer R
    Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin extended release--DepoMed: metformin, metformin gastric retention, metformin GR.
    Drugs R D; 2004; 5(4):231-3. PubMed ID: 15230631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects.
    Cho YS; Lee SH; Lim HS; Bae KS
    J Korean Med Sci; 2018 Oct; 33(41):e258. PubMed ID: 30288156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
    Hassanein M; Hanif W; Malik W; Kamal A; Geransar P; Lister N; Andrews C; Barnett A
    Curr Med Res Opin; 2011 Jul; 27(7):1367-74. PubMed ID: 21568833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medication of the month. Gliclazide modified release (Uni Diamicron)].
    Scheen AJ
    Rev Med Liege; 2003 Oct; 58(10):641-5. PubMed ID: 14677526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliclazide modified release.
    McGavin JK; Perry CM; Goa KL
    Drugs; 2002; 62(9):1357-64; discussion 1365-6. PubMed ID: 12076188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].
    Galeone F; Fiore G; Arcangeli A; Mannucci E
    Minerva Endocrinol; 1998 Sep; 23(3):71-5. PubMed ID: 10063324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.